Financial News
Latest News about MRK
Recent news which mentions MRK
2 Top Biotech Stocks To Buy Right Now
December 13, 2021
From Motley Fool
Why an FDA Panel Had Concerns About Merck's COVID-19 Pill
December 10, 2021
From Motley Fool
Here’s a list of favored dividend stocks with room to pay more for investors worried about 2022
December 10, 2021
From MarketWatch
Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?
December 10, 2021
From Motley Fool
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
Looking for the ‘hidden value’ unearths GM and other stock gems for this fund manager
December 09, 2021
From MarketWatch
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ
December 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
Is Gilead Sciences Stock a Buy Now?
December 07, 2021
From Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
3 Dow Stocks Begging to Be Bought in December
December 07, 2021
From Motley Fool
Why Vaccine Stocks Like BioNTech and Novavax Are Crashing Today
December 06, 2021
From Motley Fool
Canada, Merck Ink Supply Pact For 1M Doses Of Molnupiravir For COVID-19
December 06, 2021
Tickers
MRK
From Benzinga
Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings
December 06, 2021
Tickers
MRK
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
7 Stocks to Buy to Give Your Portfolio a Booster Shot
December 06, 2021
From InvestorPlace
Here's Why Merck Lost Nearly $40 Billion in Value During November
December 04, 2021
From Motley Fool
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
December 04, 2021
From Motley Fool
Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock
December 03, 2021
From Motley Fool
Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
3 Stocks to Buy for the New COVID Variant
December 02, 2021
From Motley Fool
Regeneron: Surfing on Covid, With More Under the Surface
December 02, 2021
From InvestorPlace
Is High Pressure Good for Drug Development?
December 02, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
